Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

NCT02271022 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 17, 2015
Completion date
October 31, 2019
Enrollment
2,000 (estimated)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes